Enhanced efficacy of radiation-induced gene therapy in mice bearing lung adenocarcinoma xenografts using hypoxia responsive elements

Cancer Science

Volumn 96, Issue 12, 2005, Pages 918-924

  Wang, Wei Dong ^a   Chen, Zheng Tang ^a   Li, Rong ^a   Li, De Zhi ^a   Duan, Yu Zhong ^a   Cao, Zheng Huai ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; GANCICLOVIR; HYPOXIA INDUCIBLE FACTOR 1; LIPOFECTAMINE; RETROVIRUS VECTOR; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; IN VIVO STUDY; IRRADIATION; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; SUICIDE GENE; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL HYPOXIA; GANCICLOVIR; GENE THERAPY; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OXYGEN CONSUMPTION; RADIOTHERAPY DOSAGE; RETROVIRIDAE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 30344449454     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00129.x     Document Type: Article

References (30)

1. Kufe D, Weichselbaum R. Radiation therapy: activation for gene transcription and the development of genetic radiotherapy-therapeutic strategies in oncology. Cancer Biol Ther 2003; 2: 326-9.
2. Datta R, Taneja N, Sukhatme VP et al. Reactive oxygen intermediates target CC (A/T) 6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci USA 1993; 90: 2419-22.
3. Xia J, Xia K, Feng Y et al. The combination of suicide gene therapy and radiation enhances the killing of nasopharyngeal carcinoma xenographs. J Radiat Res (Tokyo) 2004; 45: 281-9.
4. Hsu H, Rainov NG, Quinones A et al. Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter. Anticancer Res 2003; 23: 2723-8.
5. Hallahan DE, Weichselbaum RR. Role of gene therapy in radiation oncology. Cancer Treat Res 1998; 93: 153-67.
6. Jin GH, Jin SZ, Liu Y et al. Therapeutic effect of gene-therapy in combination with local X-irradiation in a mouse malignant melanoma model. Biochem Biophys Res Commun 2005; 330: 975-81.
7. Joki T, Nakamura M, Ohno T. Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir. Hum Gene Ther 1995; 6: 1507-13.
8. Takahashi T, Namiki Y, Ohno T. Induction of the suicide HSV-TK gene by activation of the Egr 1 promoter with radioisotopes. Hum Gene Ther 1997; 8: 827-33.
9. Advani SJ, Chmura SJ, Weichselbaum RR. Radiogenetic therapy: On the interaction of viral therapy and ionizing radiation for improving local control of tumors. Seminars Oncol 1997; 24: 633-8.
10. Hellwig-Burgel T, Stiehl DP, Wagner AE et al. Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 2005; 25: 297-310.
11. Chan NM, Rogers P, Aheme W et al. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1α induction in response to hypoxic stress and growth factors. Cancer Res 2005; 65: 4918-28.
12. Maxwell PH, Hankinson O, Pugh CW et al. The tumour supressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolyses. Nature 1999; 399: 271-5.
13. Firth JD, Ebert BL, Pugh CW et al. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci USA 1994; 91: 6496-500.
14. Binley K, Iqball S, Kingsman A et al. An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer. Gene Ther 1999; 6: 1721-7.
15. Modlich U, Paugh CW, Bicknell R. Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers. Gene Ther 2000; 7: 896-902.
16. Ido A, Uto H, Moriuchi A et al. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human α-fetoprotein promoter. Cancer Res 2001; 61: 3016-21.
17. Chadderton N, Cowen RL, Sheppard FC et al. Dual responsive promoters to target therapeutic gene expression to radiation-resistant hypoxic tumor cells. Int J Radiat Oncol Biol Phys 2005; 62: 213-22.
18. Greco O, Marples B, Dachs GU et al. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Ther 2002; 9 (20): 1403-11.
19. Aragones J, Jones DR, Martin S et al. Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-induced transcription factor 1 by low oxygen tension. J Biol Chem 2001; 276: 10 548-55.
20. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucl Acids Res 1990; 18: 3587-96.
21. Cao G, Kuriyama S, Gao J et al. Gene therapy for hepatocellular carcinoma based on tumor-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter. Euro J Cancer 2001; 37: 140-7.
22. Kim JH, Kim SH, Brown SL et al. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res 1994; 54: 6053-6.
23. Kawashita Y, Ohtsuru A, Kaneda Y et al. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation. Human Gene Ther 1999; 10: 1509-19.
24. Scott SD, Marples B, Hendry JH et al. A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther 2000; 7: 1121-5.
25. Kanczuga-Koda L, Sulkowski S, Tomaszewski J et al. Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer. Oncol Rep 2005; 14: 325-9.
26. Stefani Al, Barzon L, Castagliuolo I et al. Systemic efficacy of combined suicide/cytokine gene therapy in a murrine model of hepatocellular carcinoma. J Hepatol 2005; 42: 728-35.
27. Yeo EJ, Chun YS, Park JW. New anticancer strategies targeting HIF-1. Biochem Pharmacol 2004; 68: 1061-9.
28. Gazit G, Hung G, Chen X et al. Use of the glucose starvation-inducible glucose-regulated protein 78 Promoter in suicide gene therapy of murine fibrosarcoma. Cancer Res 1999; 59: 3100-6.
29. Shibata T, Giaccia AJ, Brown JM. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther 2000; 7: 491-8.
30. Moeller BJ, Cao Y, Li C et al. Upregulation of hypoxia-inducible factor-1α following single-dose radiotherapy: serial in vivo observations. Int J Radiat Oncol Biol Phys 2002; 54 (Suppl. 1): 220-1.